LMAT
LeMaitre Vascular, Inc. Healthcare - Medical Instruments & Supplies Investor Relations →
LeMaitre Vascular, Inc. (LMAT) closed at $106.31 as of 2026-03-20, trading 51.5% above its 200-week moving average of $70.15. The stock is currently moving closer to the line, down from 54.4% last week. With a 14-week RSI of 75, LMAT is in overbought territory.
A big spike in selling this week — 2.5x the usual volume, and the price dropped. Sometimes this kind of heavy selling marks the end of a decline. The idea is that the last reluctant holders have finally sold, leaving fewer sellers left to push the price lower.
Over the past 965 weeks of data, LMAT has crossed below its 200-week moving average 4 times. On average, these episodes lasted 34 weeks. Historically, investors who bought LMAT at the start of these episodes saw an average one-year return of +33.2%.
With a market cap of $2.4 billion, LMAT is a mid-cap stock. The company generates a free cash flow yield of 2.0%. Return on equity stands at 15.8%, a solid level. The stock trades at 6.2x book value.
Share count has increased 3.1% over three years, indicating dilution. LMAT passes our Buffett quality screen: high return on equity, low debt, and positive free cash flow.
Over the past 18.6 years, a hypothetical investment of $100 in LMAT would have grown to $1686, compared to $601 for the S&P 500. That represents an annualized return of 16.4% vs 10.1% for the index — confirming LMAT as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been growing at a 49.8% compound annual rate, with 4 consecutive years of positive cash generation.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: LMAT vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After LMAT Crosses Below the Line?
Across 4 historical episodes, buying LMAT when it crossed below its 200-week moving average produced an average return of +30.0% after 12 months (median +59.0%), compared to +10.2% for the S&P 500 over the same periods. 75% of those episodes were profitable after one year. After 24 months, the average return was +42.5% vs +28.2% for the index.
Each line shows $100 invested at the moment LMAT crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
LMAT has crossed below its 200-week MA 4 times with an average 1-year return of +33.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Dec 2007 | Nov 2009 | 100 | 62.0% | -63.7% | +2018.7% |
| Mar 2010 | Apr 2010 | 2 | 2.4% | +52.9% | +2750.3% |
| Dec 2018 | Feb 2019 | 8 | 4.4% | +61.0% | +413.1% |
| Feb 2020 | Aug 2020 | 26 | 25.6% | +82.6% | +296.7% |
| Average | 34 | — | +33.2% | — |
Frequently Asked Questions
Is LMAT below its 200-week moving average?
No. LeMaitre Vascular, Inc. (LMAT) is currently 51.5% above its 200-week moving average of $70.15. It would need to fall to $70.15 to cross below the line.
What is LMAT's 200-week moving average price?
LeMaitre Vascular, Inc.'s 200-week moving average is $70.15 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when LMAT drops below its 200-week moving average?
LMAT has crossed below its 200-week moving average 4 times in our data. On average, buying at that moment produced a one-year return of +33.2%. These dips have historically been decent entry points. These episodes lasted 34 weeks on average.
Is LMAT a good value right now?
Here's what our data says about LMAT as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 75 (overbought). Free cash flow yield is 2.0%. Return on equity is 15.8%. Price-to-book is 6.2x. This is not a buy or sell recommendation — always do your own research.
How does LMAT compare to the S&P 500?
Over the past 18.6 years, $100 invested in LMAT would have grown to $1686, compared to $601 for the S&P 500. That's 16.4% annualized vs 10.1% for the index. LMAT has outperformed the broader market over this period.
Does LMAT pay a dividend?
Yes. LeMaitre Vascular, Inc. currently pays a dividend yield of 94.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20